BridgeBio Oncology Therapeutics, Inc. (BBOT)

NASDAQ: BBOT · Real-Time Price · USD

8.72

-0.09 (-1.02%)

At close: Mar 24, 2026, 4:00 PM EDT

9.18

+0.46 (5.28%)

After-hours: Mar 24, 2026, 4:50 PM EDT

BBOT Employees

BridgeBio Oncology Therapeutics had 92 employees as of December 31, 2025. The number of employees increased by 30 or 48.39% compared to the previous year.

Employees

Change

Growth

48.39%

Revenue / Employee

n/a

Profits / Employee

-$1,457,000

Market Cap

697.89M

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	92	30	48.39%
Sep 30, 2025	81	19	30.65%
Mar 31, 2025	62	-	-
Dec 31, 2024	62	-	-

Related Stocks

Company Name	Employees
Gyre Therapeutics	625
Kura Oncology	260
Arvinas	246
Ocugen	116
Solid Biosciences	100
Theravance Biopharma	97
Lexicon Pharmaceuticals	81
Jade Biosciences	55

Employee Rankings

BBOT News

6 days ago - BBOT Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026 - GlobeNewsWire
18 days ago - BBOT Announces Publication in Cancer Discovery Highlighting Preclinical Data Demonstrating BBO-11818 is a Potent and Selective panKRAS Inhibitor - GlobeNewsWire
19 days ago - BBOT Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress - GlobeNewsWire
5 weeks ago - BBOT to Participate in Upcoming Investor Healthcare Conferences - GlobeNewsWire
5 weeks ago - BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
2 months ago - BridgeBio Oncology Therapeutics, Inc. (BBOT) Discusses Clinical Data Updates for BBO-8520, BBO-11818, and BBO-10203 Transcript - Seeking Alpha
2 months ago - BBOT Announces New Clinical Data Advancing Its Portfolio of Three Innovative and Differentiated RAS and PI3Kα Pipeline Programs - GlobeNewsWire
3 months ago - BBOT to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire

More News